登录  
 加关注
查看详情
   显示下一条  |  关闭
温馨提示!由于新浪微博认证机制调整,您的新浪微博帐号绑定已过期,请重新绑定!立即重新绑定新浪微博》  |  关闭

青山妩媚

新的一年,新的心情,新的挑战,新的起点...

 
 
 

日志

 
 

我新作的四个网页面世了  

2008-11-13 09:47:17|  分类: Bio-Pharma |  标签: |举报 |字号 订阅

  下载LOFTER 我的照片书  |
哈哈,我刚做的四个网页又终于面世了,大家帮忙上去看看啊。要是有什么错误一定赶紧通知我,要是被老板发现了可就麻烦了:

One overview page:
http://www.genscript.com/bioprocess.html
Three supporting pages:
For transient gene expression and protein production:
http://www.genscript.com/transient_gene_expression.html
For stable cell line development and protein production:
http://www.genscript.com/stable_cell_line.html
For process development and transfer:
http://www.genscript.com/process_development.html

以前曾经设计过一个关于Vector的大页面,里面用大大的Vector作为导航图可是我的创意:
http://www.genscript.com/Vectors.html


GenScript Centralizes BioProcess Services for Optimum Protein Expression
我新作的四个网页面世了 - 青山妩媚 - 青山妩媚
 Nov 12, 2008

PISCATAWAY, N.J., Nov. 12, 2008-International contract research organization GenScript Corporation has upgraded its BioProcess service platform, adding transient gene expression (TGE), stable cell line development, process development and transfer, and large-scale protein production to its centralized biology processing pipeline. GenScript anticipates that this service will appeal to both academic institutions engaged in life science research and companies engaged in industrial drug development.

GenScript TGE is both quicker and less costly than stable cell line development: GenScript employs proprietary 293 and CHO suspension systems to produce gram quantities of recombinant protein and monoclonal antibody from large-quantity medium supernatant within four to five weeks. The process involves the serum-free cell culture condition, which may facilitate downstream applications.

In GenScript stable cell line development, parental cells satisfying the production requirements are identified from a selection of 293, CHO, BHK, and NS0 cells. The growth of the primary clones is also tested for productivity and adaptability in serum-free suspension culture to identify the cell line having the most optimal traits. The genetic and production stabilities are also tested under different conditions in the presence and absence of selected agents. Moreover, the stable cell line can be linked with GenScript’s OptimumGene? gene synthesis technology, CloneEZ? cloning technology, vector design and construction, as well as many downstream protein purification and characterization assays including SDS-PAGE, IEF, HPLC, ELISA, affinity, ion exchange, and gel filtration chromatography.



The process development and transfer service involves optimization and transformation of the cell lines toward large-scale protein production. GenScript takes the growth media and feeding strategies into consideration to study cell line stability and enhance cell culture productivity and protein quality. In addition, analyses of growth rate, subcultivation ratios, cell mass, and specific and volumetric productivity levels using productivity-enhancing conditions can be used to predict the cell line performance.

GenScript offers large-scale protein production, filling orders of up to one kilogram in bacteria, yeast, baculovirus-insect, and mammalian cell expression systems using fermentors, Wave? mixers, and bioreactors.

GenScript Corporation is a reliable outsourcing partner providing a wide array of services to augment all stages of the drug discovery and biological reagent manufacturing processes, including high-quality gene synthesis and cloning, custom protein expression and purification, custom peptide synthesis and antibody development, custom stable cell line development, and a wide selection of biological reagents to life science researchers in industrial and academic settings. GenScript Corporation is headquartered in Piscataway, New Jersey.

# # # #

For further information, please contact:
Vicky Wang
GENSCRIPT CORPORATION
1-(877) 436-7274

Source: http://www.genscript.com/bioprocess.html


  评论这张
 
阅读(417)| 评论(4)

历史上的今天

评论

<#--最新日志,群博日志--> <#--推荐日志--> <#--引用记录--> <#--博主推荐--> <#--随机阅读--> <#--首页推荐--> <#--历史上的今天--> <#--被推荐日志--> <#--上一篇,下一篇--> <#-- 热度 --> <#-- 网易新闻广告 --> <#--右边模块结构--> <#--评论模块结构--> <#--引用模块结构--> <#--博主发起的投票-->
 
 
 
 
 
 
 
 
 
 
 
 
 
 

页脚

网易公司版权所有 ©1997-2018